methylation, we obtained diffraction-quality crystals for 40 of the 370 proteins, and so far we solved 26 crystal structures ( Table  1) . The crystallization success rate of methylated proteins did not correlate with the number of lysines, pI, hydropathy or molecular weight (Supplementary Table 1) .
We also determined the structures of 4 proteins in their native as well as their methylated states (Supplementary Methods). By comparing these structures, we obtained insight into how methylation affects protein crystallization. We observed a decrease in the isotropic B factor (Fig. 1) , which is likely a result of more ordered crystal packing and which leads to better diffraction limits. Indeed, the resolution of the methylated structures (average, 2.07 Å) was better than that of their native counterparts (average, 3.05 Å; Supplementary Table 1 ). The methylated lysines were engaged in various intra-and intermolecular interactions with protein and solvent (carboxylates and main chain carbonyls as reported earlier [2] [3] [4] as well as with histidine and arginine residues and water; Supplementary Figs. 1 and 2 online). Adding methyl groups effectively increases the lysine interaction radius by 1-1.2 Å, allowing a weak, long-distance ε-amine (>4.2 Å) interaction with oxygen or nitrogen to be replaced with stronger (3.3 Å) ε-amine-(N-methyl) oxygen or nitrogen interactions ( Supplementary Fig. 3 online) . Methylation of lysine may be considered as similar to replacing it with an arginine, which has a higher propensity for interactions and is found more often on protein-protein 13 and crystal packing interfaces [14] [15] [16] (Supplementary Figs. 1, 4 and 5 online). Ab initio quantum mechanical calculations using ethylamine and N,N-dimethylethyl amine model compounds (Supplementary Methods) provided an estimate of the binding energy between N-methyl groups. The computation results predicted the optimal methylated amine interaction distance with the water oxygen to be ~3.3 Å (Supplementary Fig. 3 ), consistent with observations in the crystal structures.
We showed in this large-scale study that reductive methylation of proteins provides a generally useful, simple, inexpensive and efficient method to alter protein-surface properties that can improve the crystallizability of proteins. We achieved an overall success rate, from purified protein to structure, of 7.0% for proteins that did not yield a structure in initial attempts, thus demonstrating that reductive methylation can be an effective method for increasing the chances of obtaining a structure.
Large-scale evaluation of protein reductive methylation for improving protein crystallization
To the editor: Obtaining diffraction-quality crystals is a major bottleneck in protein X-ray crystallography. For example, the current success rate for protein structure solution at the Midwest Center for Structural Genomics (starting from purified protein) is ~10%. Protein crystallization is influenced by many factors, and many methods have been developed to enhance crystallization. In particular, reductive methylation of proteins has been successfully applied to obtain high-quality crystals [1] [2] [3] [4] . Several studies 3, 5, 6 have indicated that methylating the solvent-exposed ε-amino group of lysines changes protein properties (pI, solubility and hydropathy) 7, 8 , which may promote crystallization via improving crystal packing. Reductive methylation of proteins is a simple, generic method; it is fast, specific and requires few steps under relatively mild buffer and chemical conditions and can be executed for several proteins in parallel. Native and methylated proteins have very similar structures, and, in most cases, methylated proteins maintain their biochemical function 2, 5, 9 . Some proteins can only be crystallized after methylation 3, 10 , and crystals of modified proteins often diffract to higher resolution 3, 9 . The efficacy of the method has been previously tested on 10 proteins, with a 30% success rate 3 .
Here we investigated the application of reductive methylation on a large scale. We applied a previously described reductive methylation protocol 2, 11 (Supplementary Methods online) to 370 sequence-diverse proteins selected from protein families that had no structural homologs with >30% sequence identity. We expressed 370 recombinant proteins and purified them using standard methods 12 and screened them using standard crystal screening methods (Supplementary Methods). Of the 370 proteins, 269 proteins had not previously yielded crystals suitable for structure determination (crystals were too small, poorly ordered, twinned, highly mosaic or multiple), 85 proteins had previously failed to crystallize and 16 proteins were a reference set (not previously screened for crystallization; Table  1 and Supplementary Tables 1 and 2 online) . After reductive 
A pilot project to generate affinity reagents to human proteins
To the editor: There is a great need to generate protein-specific affinity reagents to explore the human proteome. Highthroughput methods to generate renewable antibodies or other affinity reagents are still unproven, and therefore there is a need to explore systematic production of well-characterized sets of protein binders, to ultimately generate antibodies or other affinity reagents to all human proteins as a sustainable resource. This was the background for a workshop organized by the Structural Genomics Consortium 1 , the Human Protein Atlas program 2 and the EU ProteomeBinders network program 3 , and held in Stockholm in March 2008. Representatives of scientists and funders from more than 20 countries met to discuss demonstration projects to investigate the possibility of systematically generating renewable protein binders. The workshop participants agreed to launch a pilot study to generatein a decentralized and coordinated mannerprotein binders to the human SH2-containing proteins, taking advantage of a strong biological community with a commitment to take part in the binder evaluation. The first objective was to generate antigens to 22 of the human SH2-containing proteins based on the availability of both soluble protein domains 1 and partially unfolded recombinant protein fragments (protein epitope signature tags or PrESTs) selected because of their low homology to other human proteins 2 . In this way, it will be possible to compare the
